摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-[3-(Trifluoromethyl)phenyl]imidazol-2-amine | 1238312-62-3

中文名称
——
中文别名
——
英文名称
1-[3-(Trifluoromethyl)phenyl]imidazol-2-amine
英文别名
1-[3-(trifluoromethyl)phenyl]imidazol-2-amine
1-[3-(Trifluoromethyl)phenyl]imidazol-2-amine化学式
CAS
1238312-62-3
化学式
C10H8F3N3
mdl
——
分子量
227.189
InChiKey
DKGMGXGXOBPZRX-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    357.8±52.0 °C(Predicted)
  • 密度:
    1.39±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.2
  • 重原子数:
    16
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.1
  • 拓扑面积:
    43.8
  • 氢给体数:
    1
  • 氢受体数:
    5

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Discovery of novel 1H-imidazol-2-yl-pyrimidine-4,6-diamines as potential antimalarials
    摘要:
    A novel family of 1H-imidazol-2-yl-pyrimidine-4,6-diamines has been identified with potent activity against the erythrocyte-stage of Plasmodium falciparum (Pf), the most common causative agent of malaria. A systematic SAR study resulted in the identification of compound 40 which exhibits good potency against both wild-type and drug resistant parasites and exhibits good in vivo pharmacokinetic properties. (C) 2010 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2010.05.095
  • 作为产物:
    参考文献:
    名称:
    Discovery of novel 1H-imidazol-2-yl-pyrimidine-4,6-diamines as potential antimalarials
    摘要:
    A novel family of 1H-imidazol-2-yl-pyrimidine-4,6-diamines has been identified with potent activity against the erythrocyte-stage of Plasmodium falciparum (Pf), the most common causative agent of malaria. A systematic SAR study resulted in the identification of compound 40 which exhibits good potency against both wild-type and drug resistant parasites and exhibits good in vivo pharmacokinetic properties. (C) 2010 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2010.05.095
点击查看最新优质反应信息

文献信息

  • SMALL MOLECULE MYRISTATE INHIBITORS OF BCR-ABL AND METHODS OF USE
    申请人:Dana Farber Cancer Institute, Inc.
    公开号:EP3150593A1
    公开(公告)日:2017-04-05
    The present invention provides novel heteroaryl compounds that are linked to an aryl group via an amine linker. Such compounds are useful for the treatment of cancers.
    本发明提供了通过胺连接剂与芳基相连的新型杂芳基化合物。此类化合物可用于治疗癌症。
查看更多